#primary hyperoxaluria

[healthcareporium]

Primary Hyperoxaluria Treatment Insights: Market Forecast and Growth Prospects

Primary Hyperoxaluria (PH) is a rare genetic disorder causing an overproduction of oxalate, leading to kidney stones and potential organ damage. Fortunately, recent developments in treatment offer hope to patients managing this condition.Alnylam Pharmaceuticals and Novo Nordisk: Leaders in PH TreatmentAlnylam Pharmaceuticals and Novo Nordisk are at the forefront of Primary Hyperoxaluria treatment…

View On WordPress

[xhealer]

Primary Hyperoxaluria Treatment Showdown: Rivfloza vs. Oxlumo

FDA approved Rivfloza for primary hyperoxaluria treatment. This announcement comes as Novo continues to make strides in field of RNAi drugs.

Primary Hyperoxaluria (PH) is a rare genetic disorder causing an overproduction of oxalate, leading to kidney stones and potential organ damage. Fortunately, recent developments in treatment offer hope to patients managing this condition.